Navigation Links
Mylan's President of Europe, Middle East and Africa Elected President of European Generic Medicines Association

PITTSBURGH, Nov. 18 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL) today announced that Didier Barret, president of Mylan Europe, Middle East and Africa (EMEA), has been elected president of the European Generic Medicines Association (EGA). Barret was elected to a two-year term earlier today at the EGA annual meeting being held in Brussels.

Mylan Chairman and CEO Robert J. Coury said: "We are extremely pleased to have one of our own senior executives lead Europe's generic trade organization over the next two years. The EGA could not have elected a stronger leader to help guide our industry in Europe than Didier Barret. His willingness to serve EGA in this capacity emphasizes Mylan's commitment to enhance industry efforts in international markets as generic pharmaceuticals represent a proven and successful solution to rising global health care costs."

Commenting on his appointment Barret said: "I am very proud to be able to serve EGA as president. One of my goals is to replicate the kind of strong collaboration that Mylan has had with the industry associations across the world. I also look forward to continuing to help shape the European generics marketplace as a facilitator between the industry and our colleagues at health care agencies across the different European regions. Creating conditions for a sustainable and competitive generics industry within the European market will be a priority for EGA in the years ahead."

The EGA is the official representative body of the European generic and bio-similar pharmaceutical industry, which is at the forefront of providing high quality affordable medicines to millions of Europeans and stimulating competitiveness and innovation in the pharmaceutical sector. Formed in 1993, the EGA represents generic pharmaceuticals companies and their subsidiaries throughout Europe, either directly or through national associations.

Mylan Inc. ranks among the leading generic and specialty pharmaceutical companies in the world and provides products to customers in more than 140 countries and territories. The company maintains one of the industry's broadest and highest quality product portfolios supported by a robust product pipeline; operates the world's third largest active pharmaceutical ingredient manufacturer; and runs a specialty business focused on respiratory and allergy therapies. For more information, please visit

SOURCE Mylan Inc.

SOURCE Mylan Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Lexington International, LLC Receives 2009 U.S. Presidents E Award Recognizing its Export Achievements
2. IDEV Technologies Names Christopher M. Owens President, Chief Executive Officer
3. Voler Systems President Speaks at BIOMEDevice San Jose
4. Dr. Steven M. Paul to Retire from Lilly as Executive Vice President, Science and Technology, President, Lilly Research Laboratories; Dr. Jan M. Lundberg, Executive Vice President, Head of Global Discovery Research, AstraZeneca, Named his Successor
5. Gary Wenzel Named President TBWA\WorldHealth
6. Cardiac Science Appoints Peter Kingma Senior Vice President Sales and Marketing
7. VIVUS Announces Promotion of Peter Tam to President
8. Kendle Appoints J. Michael Sprafka, MPH, PhD, Vice President, Kendle Consulting
9. Jeffrey Trotter Joins Pharmanet Development Group as Executive Vice President, Phase IV Development
10. ClinOps, LLC Enhances Senior Management Team With Addition of Connie Andrews as Senior Vice President of Clinical Operations
11. Csuy Named Senior Vice President/General Merchandise Manager
Post Your Comments:
(Date:11/25/2015)... Nov. 25, 2015  Amgen (NASDAQ: AMGN ) ... (BLA) with the United States ... a biosimilar candidate to Humira ® (adalimumab). Amgen ... submitted to the FDA and represents Amgen,s first BLA ... E. Harper , M.D., executive vice president of Research ...
(Date:11/25/2015)... N.Y. , Nov. 25, 2015  Linden Care, ... and optimizing treatment outcomes for patients suffering from chronic ... request for a Temporary Restraining Order (TRO) enjoining Express ... the two companies. --> ... pursuing all of its legal options. ...
(Date:11/25/2015)... On Tuesday, November 24, 2015, the ... Wright Medical Technology, Inc. for product liability and ... implant device, awarded $11 million in favor of ... and three days of deliberations, the jury found ... designed and unreasonably dangerous, and that Wright Medical ...
Breaking Medicine Technology:
(Date:11/27/2015)... LOS ANGELES, CA (PRWEB) , ... November 27, 2015 , ... MPWH, the No.1 Herpes-only ... age of 30 (see Table 1-1 ). More than 3.7 billion people under ... simplex virus type 1 (HSV-1), according to WHO's first global estimates of HSV-1 infection ...
(Date:11/27/2015)... , ... November 27, 2015 , ... ... Secura Consultants has prided itself for not only fulfilling the needs of advisers ... solutions at an affordable price and providing top-tier customer service. However, there's always ...
(Date:11/27/2015)... ... November 27, 2015 , ... Dr. Thomas Dunlap and ... Dr. Tucker Bierbaum with Emergency Medicine at St., Joseph Health System’s Santa Rosa ... Sepsis conditions present in similar ways and require time-critical intervention to avoid large area ...
(Date:11/26/2015)... ... 26, 2015 , ... Inevitably when people think Thanksgiving, they also think Holiday ... the Black Friday and Cyber Monday massage chair sales to receive the ... and low to find the best massage chair deals, they can see all of ...
(Date:11/26/2015)... ... ... Jobs in hospital medical laboratories and in the imaging field lead the many ... Medical Group . These fields, as well as travel nursing, ranked at ... through the company’s website, , The leading healthcare staffing agency released ...
Breaking Medicine News(10 mins):